Virtu Financial’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17K Buy
19,861
+6,389
+47% +$6.06K ﹤0.01% 1369
2026
Q1
$14K Buy
+13,472
New +$22.8K ﹤0.01% 1433
2024
Q4
Sell
-1,598
Closed -$12K 2098
2024
Q3
$12K Buy
+1,598
New +$51.3K ﹤0.01% 1187
2023
Q4
Sell
-196
Closed -$17K 2050
2023
Q3
$17K Buy
196
+129
+193% +$15K ﹤0.01% 1038
2023
Q2
$12K Buy
+67
New +$15.4K ﹤0.01% 1332
2022
Q3
Sell
-7
Closed -$20K 2276
2022
Q2
$20K Sell
7
-13
-65% -$40.2K ﹤0.01% 1331
2022
Q1
$77K Buy
20
+17
+567% +$116K 0.01% 1033
2021
Q4
$41K Buy
3
+2
+200% +$47.7K ﹤0.01% 1383
2021
Q3
$41K Sell
1
-5
-83% -$157K ﹤0.01% 1300
2021
Q2
$269K Buy
6
+3
+100% +$125K 0.03% 794
2021
Q1
$137K Buy
+3
New +$196K 0.01% 1217

Other funds holding VTAK

Virtu Financial's VTAK Position: Q2 2026 in Review

Virtu Financial increased its Catheter Precision (VTAK) stake by 47% in Q2 2026, buying an estimated $6.06K and bringing the position to 19,861 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1369.

Virtu Financial first reported a position in VTAK in Q1 2021 and has held it in 11 quarters since. The position peaked at $269K in Q2 2021. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2026.

  • Virtu Financial held 19,861 shares of Catheter Precision worth $17K as of Q2 2026.
  • Virtu Financial bought 6,389 Catheter Precision shares in Q2 2026, an estimated $6.06K.
  • Catheter Precision made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1369 holding.
  • Virtu Financial first reported a position in Catheter Precision in Q1 2021 and has held it in 11 quarters since.
  • Virtu Financial's Catheter Precision position peaked at $269K in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.